Céline Lepère

Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

Christophe Louvet, Roberto Labianca, Pascal Hammel et al. · Journal of Clinical Oncology · 2005 · 954 citations · Full text

Medicine, Oncology, Pharmacology +12

Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study

Nadine Attal, Didier Bouhassira, M. Gautron et al. · Pain · 2009 · 188 citations

Medicine, Oncology, Chemotherapy +16

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

Alix Portal, Simon Pernot, David Tougeron et al. · British Journal of Cancer · 2015 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

Thierry André, Déwi Vernerey, Laurent Mineur et al. · Journal of Clinical Oncology · 2018 · 174 citations

Medicine, Oncology, Pharmacology +17

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV

Françis Lévi, Valérie Boige, Mohamed Hebbar et al. · Annals of Oncology · 2015 · 148 citations

Medicine, Oncology, Surgery +17